Pharmaceutics & Novel Drug Delivery Systems

Novel Drug Delivery Systems for Biologics and Gene Therapy

Novel drug delivery systems have revolutionized the field of biologics and gene therapy, enabling the effective delivery of these complex therapeutics. This session will focus on the advancements and applications of novel drug delivery systems specifically designed for biologics and gene therapy.

Biologics, such as monoclonal antibodies, proteins, and nucleic acids, hold great promise for the treatment of various diseases. However, their large size, susceptibility to degradation, and limited stability present challenges in delivery. The session will explore innovative approaches, including nanoparticle-based systems, viral vectors, and lipid-based carriers, to overcome these hurdles and enhance the delivery of biologics. Gene therapy, with its potential to treat genetic disorders by introducing therapeutic genes, requires efficient and targeted delivery systems. The session will discuss viral and non-viral vectors, gene editing technologies, and innovative gene delivery platforms to facilitate safe and effective gene therapy.

Attendees will gain insights into the design, formulation, and optimization of these novel drug delivery systems for biologics and gene therapy. Discussions will cover topics such as stability, scalability, immunogenicity, and regulatory considerations. The session will also highlight the clinical applications and therapeutic breakthroughs made possible by these novel drug delivery systems, providing a platform for researchers, clinicians, and industry professionals to exchange knowledge, foster collaborations, and shape the future of biologics and gene therapy delivery.